This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 Jun;36(6):1454-61.
doi: 10.2337/dc12-1652. Epub 2012 Dec 28.

Grape polyphenols prevent fructose-induced oxidative stress and insulin resistance in first-degree relatives of type 2 diabetic patients

Affiliations
Randomized Controlled Trial

Grape polyphenols prevent fructose-induced oxidative stress and insulin resistance in first-degree relatives of type 2 diabetic patients

Marie Hokayem et al. Diabetes Care. 2013 Jun.

Abstract

Objective: To assess the clinical efficacy of nutritional amounts of grape polyphenols (PPs) in counteracting the metabolic alterations of high-fructose diet, including oxidative stress and insulin resistance (IR), in healthy volunteers with high metabolic risk.

Research design and methods: Thirty-eight healthy overweight/obese first-degree relatives of type 2 diabetic patients (18 men and 20 women) were randomized in a double-blind controlled trial between a grape PP (2 g/day) and a placebo (PCB) group. Subjects were investigated at baseline and after 8 and 9 weeks of supplementation, the last 6 days of which they all received 3 g/kg fat-free mass/day of fructose. The primary end point was the protective effect of grape PPs on fructose-induced IR.

Results: In the PCB group, fructose induced 1) a 20% decrease in hepatic insulin sensitivity index (P < 0.05) and an 11% decrease in glucose infusion rate (P < 0.05) as evaluated during a two-step hyperinsulinemic-euglycemic clamp, 2) an increase in systemic (urinary F2-isoprostanes) and muscle (thiobarbituric acid-reactive substances and protein carbonylation) oxidative stress (P < 0.05), and 3) a downregulation of mitochondrial genes and decreased mitochondrial respiration (P < 0.05). All the deleterious effects of fructose were fully blunted by grape PP supplementation. Antioxidative defenses, inflammatory markers, and main adipokines were affected neither by fructose nor by grape PPs.

Conclusions: A natural mixture of grape PPs at nutritional doses efficiently prevents fructose-induced oxidative stress and IR. The current interest in grape PP ingredients and products by the global food and nutrition industries could well make them a stepping-stone of preventive nutrition.

Trial registration: ClinicalTrials.gov NCT01478841.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Protective effects of grape PP supplementation on HFrD-induced oxidative stress. Linking oxidative stress to IR, from baseline (white bars) to post–8 weeks of PCB or grape PP supplementation (gray bars) and after 6 days of HFrD with PCB/grape PP supplementations (black bars) with urinary F2-isiprostanes (Isop) (picomoles per millimole of creatinine [creat]) (18 PCB and 20 PP) (A), TBARS (nanomoles per gram of tissue) (8 PCB and 8 PP) (B), and muscle protein carbonylation as fold induction relative to baseline (arbitrary units [AU]) (8 PCB and 13 PP) (C). *P < 0.05 for statistical pre- and postintervention comparisons within each group via the Wilcoxon signed rank sum test. #P < 0.05 for intergroup comparisons by Mann-Whitney U tests. Data are means ± SEM.
Figure 2
Figure 2
Differentially regulated biological pathways in response to HFrD and protective effects of grape PP supplementation on fructose-induced alterations of mitochondrial genes and a major transcription factor of mitochondrial biogenesis. A: Analysis of the 277 differentially regulated probes in response to fructose load between both groups was performed with Babelomics (http://babelomics.bioinfo.cipf.es/index.html). Only biological processes with adjusted P value <0.05 and fold enrichment >2 are displayed. Change in mRNA levels of skeletal muscle CKMT2 (B), CPT1B (C), and UCP3 (D) and regulation of PGC-1α mRNA (E), expressed by reference to hypoxanthine guanine phosphoribosyl transferase mRNA abundance, at baseline (white bars), after 8 weeks of PCB or grape PP supplementation (gray bars), and after 6 days of HFrD with PCB/PP supplementations (black bars). Transcript levels were measured by reverse transcriptase–quantitative PCR as described in research design and methods (11 PCB and 12 PP). *P < 0.05 for statistical pre- and postintervention comparisons within each group via the Wilcoxon signed rank sum test; Mann-Whitney U test was used for intergroup comparisons. Data are means ± SEM. AU, arbitrary units.
Figure 3
Figure 3
Protective effects of grape PP supplementation against HFrD-induced mitochondrial dysfunction. Mitochondrial functional adaptations at baseline (white bars), after 8 weeks of PCB or grape PP supplementation (gray bars), and after 6 days of HFrD with PCB or PP supplementation (black bars). A and C: Mitochondrial V0 without ADP in the presence of pyruvate or palmitoyl-l-carnitine (V0) (micromoles O2 per minute per gram of fibers) (seven PCB and nine PP) on the left, and on the right, basal measures of respiration are divided by citrate synthase activity to correct for mitochondrial content. B and D: ADP-stimulated mitochondrial Vmax rate (micromoles O2 per minute per gram of fibers) (seven PCB and nine PP) in the presence of pyruvate or palmitoyl-l-carnitine on the left, and on the right, Vmax is divided by citrate synthase activity to correct for mitochondrial content. *P < 0.05 for statistical pre- and postintervention comparisons within each group via the Wilcoxon signed rank sum test. #P < 0.05 for intergroup comparisons by Mann-Whitney U tests. Correlations were established with Spearman rank correlations tests; data are means ± SEM.

References

    1. Monteiro CA, Cannon G. The impact of transnational "big food" companies on the South: a view from Brazil. PLoS Med 2012;9:e1001252. - PMC - PubMed
    1. Tappy L, Lê KA, Tran C, Paquot N. Fructose and metabolic diseases: new findings, new questions. Nutrition 2010;26:1044–1049 - PubMed
    1. Busserolles J, Gueux E, Rock E, Mazur A, Rayssiguier Y. High fructose feeding of magnesium deficient rats is associated with increased plasma triglyceride concentration and increased oxidative stress. Magnes Res 2003;16:7–12 - PubMed
    1. Dekker MJ, Su Q, Baker C, Rutledge AC, Adeli K. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab 2010;299:E685–E694 - PubMed
    1. De Lorgeril M, Salen P, Martin JL, et al. Effect of a mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease. Insights into the cardioprotective effect of certain nutriments. J Am Coll Cardiol 1996;28:1103–1108 - PubMed

Publication types

Associated data

Full text links
Silverchair Information Systems full text link Silverchair Information Systems Free PMC article
Cite

AltStyle によって変換されたページ (->オリジナル) /